The surging prevalence of spinal cord injuries coupled with the rising geriatric population and other spine-related problems resulting in the need for spinal treatments. As per WHO, around 250 000 to 500 000 people globally suffer a spinal cord injury (SCI) every year. Most of the spinal cord injuries happen due to preventable causes such as road traffic crashes, falls, or violence, etc. Kyphoplasty is a vertebral augmentation surgery that is used to treat a spinal compression fracture. These fractures also occur because of conditions such as osteoporosis or trauma. Osteoporotic vertebral fractures have associations with increased morbidity. Kyphoplasty procedure provides pain relief and improves spinal support function. Moreover, the benefits of kyphoplasty such as less pain, easy and quick procedure, and quick recovery are acting as a growth catalyst to the market. As per a survey by the US National Library of Medicine
National Institutes of Health, out of a total of 151 people, 144 responded that e-procedure to inject cement into your fracture tolerable while 7 responded that the procedure was not tolerable. Also, 100 people said that they would have the same procedure again while 24 said no and 27 were not sure about that. Also, in a survey, around 57% out of a total of 310 people are satisfied or better with the surgery for the treatment of back pain.
Escalating the aging population globally that are suffering from osteoporosis is also supporting the growth of the demand for kyphoplasty surgery. As per a report by United Nations, "There were 703 million persons aged 65 years or over in the world in 2019 and the number of older persons is projected to double to 1.5 billion in 2050". Also, half of the world's population aged 65 and older suffer from osteoarthritis, and 80 % of people with symptomatic Osteoarthritis have limitations in movement, while 25 % were not able to perform their normal daily activities.
According to the National Spinal Cord Injury Statistical Center, the distribution of the causes of spinal cord injury has changed drastically from 2015 to 2019. Around 39.3% of the spinal cord injuries are due to motor vehicle crashes while 31.8% are due to falls. Moreover, the average age at injury has moved from 29 years in the 1970s to 43 years in 2018.
Some Stats related to people with Spinal Cord Injury are:
- Every year, around the world, between 250,000 and 500,000 people suffer a spinal cord injury (SCI)
- Up to 90% of cases are due to traumatic causes, though the proportion of non-traumatic spinal cord injury appears to be growing
- People with spinal cord injury are 2 to 5 times more likely to die prematurely than people without SCI.
- About of new SCI cases are 78% male, 22% female
- The highest per capita rate of injury occurs between ages 16-30
- The average age at injury - 43
- Motor vehicle accidents are the leading cause of SCI (39.3%), followed by falls (31.8%), acts of violence (13.5%), sports (8%), medical/surgical (4.3%), and other (3.1%)
- The most common cause of death is a respiratory ailment, whereas, in the past, it was renal failure. An increasing number of people with SCI are dying of unrelated causes such as cancer or cardiovascular disease, like that of the general population
Based on the product type, the kyphoplasty market is bifurcated into the balloon, Cement Mixing, Needle, X-Ray devices, and Delivery devices. Products such as needles and cement Mixing are common for both Vertebroplasty and Kyphoplasty procedures. While X-Ray and Delivery accessories are required for any surgery. The balloon segment generated revenue of US$ 512 million in 2019 and is expected to grow at the highest CAGR of 14.06% during the forecast period to reach a market valuation of US$ 1.44 billion by 2027.
Based on the application, the kyphoplasty market is bifurcated to Kyphosis, Spinal Fractures, and Vertebral Alignment Restoration. Surging cases of road accidents and escalating aging population across the globe resulting in the demand for kyphoplasty surgery. The Spinal fracture segment captured the major market share and account for approximately 43.12% in the global kyphoplasty market.
For a better understanding of the market penetration of kyphoplasty, the market is analyzed based on its worldwide presence in the region such as North America (US, Canada, Rest of North America), Europe (Germany, UK, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific), and Rest of World. North America constitutes a major market for the kyphoplasty industry. Some of the major players operating in the market include Stryker Corporation, Medtronic, CareFusion, Alphatec Spine, Osseon LLC, DePuy Synthes (Johnson & Johnson Services), Globus Medical, Zimmer Biomet, etc.
The global kyphoplasty market was valued at US$ 1.29 billion in 2019 and is projected to expand significantly with a CAGR of 12.66% from 2021-2027. The global kyphoplasty market is expected to witness a boost, owing to the escalating number of patients with spine-related problems coupled with the surging prevalence of orthopedic. Also, the adoption of advancements in technologies in the healthcare sector is contributing to the demand for kyphoplasty.
A rise in the cases of spinal cord injury owing to the prevalence of osteoarthritis among the elderly population coupled with the escalating motor vehicle accident and the falls, acts of violence, sports, and medical/surgical reasons are resulting in the rising number of cases of spinal fractures, due to which the market for kyphoplasty is witnessing an uptick. As per WHO, every year, around the world, between 250 000 and 500 000 people suffer a spinal cord injury (SCI). Also, more than 200 million people in the world got affected by osteoporosis and more than 8.9 million fractures occur each year, as revealed by the World Journal of Orthopedics. Also, as per a study 5,900,000 spinal surgeries happened in 2019 and It is forecasted that the volume of spinal surgery would grow around 8.4% CAGR during 2019-22.
Moreover, transforming healthcare sector and the advancement in technology coupled with the use of technologies such as IoT, AI, and robotics in the healthcare industry and rising awareness about advantages of kyphoplasty surgery such as shorter surgical time, recovery at a faster speed, discharge at the same day of the procedure, etc. are gaining end-users traction. Moreover, in a survey, it was found that successful patient outcomes following kyphoplasty are 72% Improvement in back pain, 59% Improvement in back function, and 58% improvement in the quality of life. Therefore, the demand for kyphoplasty is promulgating.
Change in lifestyle owing to the hectic and busy schedule has increased the spinal problems due to bad posture, long sitting hours, and unhealthy diet. As per the International Osteoporosis Foundation (IOF), 1 in 3 women over the age of 50 years and 1 in 5 men will experience osteoporotic fractures in their lifetime globally. Furthermore, the rising geriatric population which is more prone to the osteoporotic problem is expected to add pace to the surging demand for the kyphoplasty market in the forecast period as well. In a study, it was revealed that by 2020, the impact of an aging and obese population is expected to double the number of people with OA.
The global kyphoplasty market is highly fragmented. The availability of numerous global and local players across regions makes the industry highly competitive. The key players with a considerable market share in the industry are Merit medical systems, Stryker Corporation, Medtronic, CareFusion, Alphatec Spine, Osseon LLC, DePuy Synthes, Globus Medical, Zimmer Biomet, and Parallax health sciences. Several M&A's along with partnerships have been undertaken by these players to facilitate costumers with hi-tech and innovative products.
Insights Presented in the Report
"Amongst product type, Balloon segment holds the major share"
Based on product type, the market is fragmented into Balloon, Cement Mixing, Needle, X-Ray Device, and Delivery Devices. The balloon segment dominated the market with a share of 39.8% in 2019 and is expected to maintain its dominance during the forecast period on account of the increased consumer preference for balloon kyphoplasty owing to the advantages such as less pain, quick procedure, etc.
"Amongst application type, spinal fractures is expected to dominate the market during the analyzed period"
Based on the market segment by application type, the market is segmented into kyphosis, spinal fractures, and vertebral alignment restoration. In 2019, Spinal fractures grabbed the major market share and accounted for 43.1% of the market revenue share. Surging cases of road accidents and the prevalence of spine-related problems resulting in the demand for the growing market of spinal fracture kyphosis market. Moreover, the kyphosis segment is expected to grow with a CAGR of 12.96% during the forecast period of 2021-27.
"Amongst end-user type, hospital segment accounts for the highest revenue share"
Based on the market segment by end-user type, the market is segmented into hospitals, clinics, and ambulatory surgical centers. In 2019, hospital segment accounted for the highest revenue share by capturing 61.4% of the total market. However, the ambulatory surgical centers segment is expected to grow at a CAGR of 13.8% during the forecast period of 2021-27.
"North America represents one of the largest markets of kyphoplasty market"
For a better understanding of the market dynamics of the kyphoplasty market, a detailed analysis was conducted for different regions across the globe including North America (the U.S, Canada, and the Rest of North America), Europe (Germany, France, Italy, United Kingdom, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of APAC) and Rest of the World has been conducted. North America dominated the market and generated revenue of US$ 732 million in 2019 owing to the escalating healthcare IT investment in the countries such as the U.S and Canada. In addition, the presence of well-established players and the latest technology upgraded products and services make the region dominant across the globe.
Reasons to buy this report:
- The study includes market sizing and forecasting analysis validated by authenticated key industry experts
- The report presents a quick review of overall industry performance at one glance
- The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
- Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
- The study comprehensively covers the market across different segments
- Deep dive regional level analysis of the industry
Customization Options:
The Kyphoplasty Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
Table of Contents
1. MARKET INTRODUCTION 12
1.1 Market Definition 12
1.2 The objective of the Study 12
1.3 Limitation 12
1.4 Stakeholders 13
1.5 Currency used in the Report 13
1.6 Scope of the Global Kyphoplasty Market Study 13
2. RESEARCH METHODOLOGY OR ASSUMPTION 14
2.1 Research Methodology for the Kyphoplasty Market Study 14
2.1.1 The main objective of the Kyphoplasty Market Study 15
3. INDUSTRY PERFORMANCE 16
4. EXECUTIVE SUMMARY 17
5. MARKET OVERVIEW 20
5.1 Introduction 20
5.2 Market Dynamics 21
5.2.1 Market Trend & Drivers 21
5.2.1.1 Surging Prevalence of Osteoporosis 21
5.2.1.2 Improving Healthcare Infrastructure 23
5.2.1.3 Increasing Preference for Minimally Invasive Surgeries 23
5.2.2 Market Challenges 24
5.2.2.1 High Cost of Treatment of Kyphoplasty Surgery 24
5.2.2.2 Lack of Skilled Healthcare Technology Professionals in Developing Nations 24
5.2.3 Market Opportunities 25
5.2.3.1 Surging Adoption of Technologies such as AI, ML, and IoT in Healthcare 25
5.2.3.2 The offering of Technologically Advanced Devices and End-User's Preference for Them 25
6. LEGAL & REGULATORY FRAMEWORK 26
6.1 General Overview 26
7. DEMAND AND SUPPLY SIDE ANALYSIS 27
7.1 Demand Side Analysis 27
7.2 Supply Side Analysis 28
7.2.1 Top Product Launches 29
7.2.2 Top Mergers and Acquisitions 29
7.2.3 Top Start-ups under Kyphoplasty Sector 30
8. VALUE CHAIN ANALYSIS 31
8.1 Value Chain Analysis 31
9. MARKET INSIGHTS BY PRODUCT TYPE 32
9.1 General Overview 32
9.1.1 Balloon 33
9.1.2 Cement Mixing 35
9.1.3 Needle 35
9.1.4 X-Ray Device 36
9.1.5 Delivery Devices 37
10. MARKET INSIGHTS BY APPLICATION 39
10.1 General Overview 39
10.1.1 Spinal Fractures 40
10.1.2 Kyphosis 42
10.1.3 Vertebral Alignment 43
11. MARKET INSIGHTS BY END-USER 44
11.1 General Overview 44
11.1.1 Ambulatory Surgical Centres 45
11.1.2 Clinics 48
11.1.3 Hospital 49
12. MARKET INSIGHTS BY REGION 50
12.1 General Overview 50
12.2 North America Kyphoplasty Market 53
12.2.1 United States Kyphoplasty Market 55
12.2.2 Canada Kyphoplasty Market 58
12.2.3 Rest of North America Kyphoplasty Market 61
12.3 Europe Kyphoplasty Market 64
12.3.1 U.K. Kyphoplasty Market 66
12.3.2 France Kyphoplasty Market 69
12.3.3 Germany Kyphoplasty Market 72
12.3.4 Spain Kyphoplasty Market 74
12.3.5 Italy Kyphoplasty Market 76
12.3.6 Rest of Europe Kyphoplasty Market 78
12.4 Asia Pacific Kyphoplasty Market 81
12.4.1 Japan Kyphoplasty Market 83
12.4.2 China Kyphoplasty Market 86
12.4.3 India Kyphoplasty Market 89
12.4.4 Australia Kyphoplasty Market 91
12.4.5 South Korea Kyphoplasty Market 93
12.4.6 Rest of Asia Pacific Kyphoplasty Market 95
12.5 Rest of the World Kyphoplasty Market 98
13. COMPETITIVE SCENARIO 101
13.1 Porter's Five forces analysis 101
13.1.1 Bargaining power of Supplier 102
13.1.2 Bargaining power of Buyer 102
13.1.3 Industry Rivalry 102
13.1.4 Availability of Substitute 102
13.1.5 Threat of new Entrants 103
13.2 Competitive Landscape 103
13.2.1 Market Share of Key Players in Kyphoplasty Market, 2019 104
14. TOP COMPANY PROFILES 105
14.1 Merit Medical Systems 105
14.1.1 Key Facts 105
14.1.2 Business Description 106
14.1.3 Key Product/Services Offerings 106
14.1.4 Growth Strategy 108
14.1.5 SWOT Analysis 109
14.1.6 Key Financials 110
14.1.6.1 Revenue Split 111
14.1.7 Recent Developments 111
14.1.7.1 Product Launch 111
14.1.7.2 Partnerships Mergers and Acquisitions 111
14.2 Stryker Corporation 112
14.3 Medtronic 118
14.4 CareFusion 124
14.5 Alphatec Spine 130
14.6 Osseon LLC 136
14.7 DePuy Synthes 142
14.8 Globus Medical 148
14.9 Zimmer biomet 154
14.10 Parallax Health Sciences 160
List of Tables
TABLE 1 Respondent Ratings on the Back Pain Before and After Kyphoplasty 27
TABLE 2 Top Product Launches 29
TABLE 3 Top Mergers and Acquisitions 29
TABLE 4 Professional Fees for Standard Vertebroplasty and Balloon Kyphoplasty 34
TABLE 5 Merit Medical Systems Key Facts 105
TABLE 6 Merit Medical Systems, Ownership Structure 105
TABLE 7 Product segmentation of Merit Medical Systems 106
TABLE 8 Merit Medical Systems Growth Strategy 108
TABLE 9 Merit Medical Systems Product Launch 111
TABLE 10 Merit Medical Systems Mergers and Acquisitions 111
TABLE 11 Stryker Corporation, Key Facts 112
TABLE 12 Stryker Corporation, Ownership Structure 112
TABLE 13 Products segmentation of Stryker Corporation 113
TABLE 14 Stryker Corporation, Growth Strategy 113
TABLE 15 Stryker Corporation, Product Launches 116
TABLE 16 Stryker Corporation, Partnerships 117
TABLE 17 Stryker Corporation, Mergers and Acquisitions 117
TABLE 18 Stryker Corporation, Business Expansions, Investment and Divestitures 117
TABLE 19 Medtronic, Key Facts 118
TABLE 20 Medtronic, Ownership Structure 118
TABLE 21 Products segmentation of Medtronic 119
TABLE 22 Medtronic, Growth Strategy 119
TABLE 23 Medtronic, Product Launches 122
TABLE 24 Medtronic, Partnerships 123
TABLE 25 Medtronic, Mergers and Acquisitions 123
TABLE 26 Medtronic, Business Expansions, Investment and Divestitures 123
TABLE 27 CareFusion, Key Facts 124
TABLE 28 CareFusion, Ownership Structure 124
TABLE 29 Products segmentation of CareFusion 125
TABLE 30 CareFusion, Growth Strategy 125
TABLE 31 CareFusion, Product Launches 128
TABLE 32 CareFusion, Partnerships 129
TABLE 33 CareFusion, Mergers and Acquisitions 129
TABLE 34 CareFusion, Business Expansions, Investment and Divestitures 129
TABLE 35 Alphatec Spine, Key Facts 130
TABLE 36 Alphatec Spine, Ownership Structure 130
TABLE 37 Products segmentation of Alphatec Spine 131
TABLE 38 Alphatec Spine, Growth Strategy 131
TABLE 39 Alphatec Spine, Product Launches 134
TABLE 40 Alphatec Spine, Partnerships 135
TABLE 41 Alphatec Spine, Mergers and Acquisitions 135
TABLE 42 Alphatec Spine, Business Expansions, Investment and Divestitures 135
TABLE 43 Osseon LLC, Key Facts 136
TABLE 44 Osseon LLC, Ownership Structure 136
TABLE 45 Products segmentation of Osseon LLC 137
TABLE 46 Osseon LLC, Growth Strategy 137
TABLE 47 Osseon LLC, Product Launches 140
TABLE 48 Osseon LLC, Partnerships 141
TABLE 49 Osseon LLC, Mergers and Acquisitions 141
TABLE 50 Osseon LLC, Business Expansions, Investment and Divestitures 141
TABLE 51 DePuy Synthes, Key Facts 142
TABLE 52 DePuy Synthes, Ownership Structure 142
TABLE 53 Products segmentation of DePuy Synthes 143
TABLE 54 DePuy Synthes, Growth Strategy 143
TABLE 55 DePuy Synthes, Product Launches 146
TABLE 56 DePuy Synthes, Partnerships 147
TABLE 57 DePuy Synthes, Mergers and Acquisitions 147
TABLE 58 DePuy Synthes, Business Expansions, Investment and Divestitures 147
TABLE 59 Globus Medical, Key Facts 148
TABLE 60 Globus Medical, Ownership Structure 148
TABLE 61 Products segmentation of Globus Medical 149
TABLE 62 Globus Medical, Growth Strategy 149
TABLE 63 Globus Medical, Product Launches 152
TABLE 64 Globus Medical, Partnerships 153
TABLE 65 Globus Medical, Mergers and Acquisitions 153
TABLE 66 Globus Medical, Business Expansions, Investment and Divestitures 153
TABLE 67 Zimmer biomet, Key Facts 154
TABLE 68 Zimmer biomet, Ownership Structure 154
TABLE 69 Products segmentation of Zimmer biomet 155
TABLE 70 Zimmer biomet, Growth Strategy 155
TABLE 71 Zimmer biomet, Product Launches 158
TABLE 72 Zimmer biomet, Partnerships 159
TABLE 73 Zimmer biomet, Mergers and Acquisitions 159
TABLE 74 Zimmer biomet, Business Expansions, Investment and Divestitures 159
TABLE 75 Parallax Health Sciences, Key Facts 160
TABLE 76 Parallax Health Sciences, Ownership Structure 160
TABLE 77 Products segmentation of Parallax Health Sciences 161
TABLE 78 Parallax Health Sciences, Growth Strategy 161
TABLE 79 Parallax Health Sciences, Product Launches 164
TABLE 80 Parallax Health Sciences, Partnerships 165
TABLE 81 Parallax Health Sciences, Mergers and Acquisitions 165
TABLE 82 Parallax Health Sciences, Business Expansions, Investment and Divestitures 165
List of Figures
FIG. 1 Scope of the Global Kyphoplasty Market Study 13
FIG. 2 Research Methodology for the Kyphoplasty Market Study 14
FIG. 3 The Prevalence of Traumatic Spine Injury (Persons Affected Per Annum) in the WHO region 17
FIG. 4 People Percentage Satisfied or Better with the Type of Treatment for Back Pain 18
FIG. 5 Global Kyphoplasty Market, 2019-2027 (US$ Billion) 19
FIG. 6 Healthcare Spending by Government, By Countries, 2015 & 2019, US$ per Capita 20
FIG. 7 Global Procedure Volume Estimates by Surgery Type 21
FIG. 8 Leading Cause of Spinal Cord Injury in Percentage Since 2015 22
FIG. 9 World Population Ageing, 2019 -2050 22
FIG. 10 Cause of Paralysis (N=5,596,000) in the United States 27
FIG. 11 Value Perspective in Value Chain 31
FIG. 12 Global Kyphoplasty Market Share by Product Type, 2019 & 2027 (%) 32
FIG. 13 Global Kyphoplasty Market Size by Product Type, 2019-2027 (US$ Billion) 33
FIG. 14 Global Balloon Kyphoplasty Market by Region, 2019-2027 (US$ Billion) 34
FIG. 15 Global Cement Mixing Kyphoplasty Market by Region, 2019-2027 (US$ Billion) 35
FIG. 16 Global Needle Kyphoplasty Market by Region, 2019-2027 (US$ Billion) 36
FIG. 17 Global X-Ray Device Kyphoplasty Market by Region, 2019-2027 (US$ Billion) 37
FIG. 18 Global Delivery Devices Kyphoplasty Market by Region, 2019-2027 (US$ Billion) 38
FIG. 19 Global Kyphoplasty Market Share by Application, 2019 & 2027 (%) 39
FIG. 20 Global Kyphoplasty Market Size by Application, 2019-2027 (US$ Billion) 40
FIG. 21 Prevalence of Spinal Column Fracture (Percentages) by Age Group 41
FIG. 22 Global Spinal Fractures Kyphoplasty Market by Region, 2019-2027 (US$ Billion) 41
FIG. 23 Global Kyphosis Kyphoplasty Market by Region, 2019-2027 (US$ Billion) 42
FIG. 24 Global Vertebral Alignment Kyphoplasty Market by Region, 2019-2027 (US$ Billion) 43
FIG. 25 WHO Region Healthcare Facility Registration Count as of 2017 44
FIG. 26 Global Kyphoplasty Market Share by End-User, 2019 & 2027 (%) 45
FIG. 27 Global Kyphoplasty Market Size by End-Users, 2019-2027 (US$ Billion) 45
FIG. 28 Specialties Performed in Multi-Specialty, Medicare-certified ASCs 46
FIG. 29 Global Hospitals Kyphoplasty Market by Region, 2019-2027 (US$ Billion) 47
FIG. 30 North America, Ambulatory Surgical Centre Count, By States 47
FIG. 31 Global Clinics Kyphoplasty Market by Region, 2019-2027 (US$ Billion) 48
FIG. 32 Global Hospital Kyphoplasty Market by Region, 2019-2027 (US$ Billion) 49
FIG. 33 Global Kyphoplasty Market Share by Region, 2019 & 2027 (%) 50
FIG. 34 Health Spending (Total % of GDP), 2015-2019 51
FIG. 35 Global Kyphoplasty Market Size by Region, 2019-2027 (US$ Billion) 52
FIG. 36 North America Kyphoplasty Market Size by Product Type, 2019-2027 (US$ Billion) 53
FIG. 37 North America Kyphoplasty Market, By Application, 2019-2027 (US$ Billion) 54
FIG. 38 North America Kyphoplasty Market, By End-User, 2019-2027 (US$ Billion) 54
FIG. 39 North America Kyphoplasty Market Size by Country, 2019-2027 (US$ Billion) 55
FIG. 40 United States Kyphoplasty Market Size by Product Type, 2019-2027 (US$ Billion) 56
FIG. 41 United States Kyphoplasty Market, By Application, 2019-2027 (US$ Billion) 57
FIG. 42 United States Kyphoplasty Market, By End-Users, 2019-2027 (US$ Billion) 57
FIG. 43 Canada Kyphoplasty Market Size by Product Type, 2019-2027 (US$ Billion) 59
FIG. 44 Canada Kyphoplasty Market, By Application, 2019-2027 (US$ Billion) 60
FIG. 45 Canada Kyphoplasty Market, By End-Users, 2019-2027 (US$ Billion) 60
FIG. 46 Rest of North America Kyphoplasty Market Size by Product Type, 2019-2027 (US$ Billion) 62
FIG. 47 Rest of North America Kyphoplasty Market, By Application, 2019-2027 (US$ Billion) 62
FIG. 48 Rest of North America Kyphoplasty Market, By End-Users, 2019-2027 (US$ Billion) 63
FIG. 49 Europe Kyphoplasty Market Size by Product Type, 2019-2027 (US$ Billion) 64
FIG. 50 Europe Kyphoplasty Market, By Application, 2019-2027 (US$ Billion) 65
FIG. 51 Europe Kyphoplasty Market, By End-User, 2019-2027 (US$ Billion) 65
FIG. 52 Europe Kyphoplasty Market Size by Country, 2019-2027 (US$ Billion) 66
FIG. 53 U.K. Kyphoplasty Market Size by Product Type, 2019-2027 (US$ Billion) 67
FIG. 54 U.K. Kyphoplasty Market, By Application, 2019-2027 (US$ Billion) 68
FIG. 55 U.K. Kyphoplasty Market, By End-Users, 2019-2027 (US$ Billion) 68
FIG. 56 France Kyphoplasty Market Size by Product Type, 2019-2027 (US$ Billion) 70
FIG. 57 France Kyphoplasty Market, By Application, 2019-2027 (US$ Billion) 71
FIG. 58 France Kyphoplasty Market, By End-Users, 2019-2027 (US$ Billion) 71
FIG. 59 Germany Kyphoplasty Market Size by Product Type, 2019-2027 (US$ Billion) 73
FIG. 60 Germany Kyphoplasty Market, By Application, 2019-2027 (US$ Billion) 73
FIG. 61 Germany Kyphoplasty Market, By End-Users, 2019-2027 (US$ Billion) 74
FIG. 62 Spain Kyphoplasty Market Size by Product Type, 2019-2027 (US$ Billion) 75
FIG. 63 Spain Kyphoplasty Market, By Application, 2019-2027 (US$ Billion) 75
FIG. 64 Spain Kyphoplasty Market, By End-Users, 2019-2027 (US$ Billion) 76
FIG. 65 Italy Kyphoplasty Market Size by Product Type, 2019-2027 (US$ Billion) 77
FIG. 66 Italy Kyphoplasty Market, By Application, 2019-2027 (US$ Billion) 77
FIG. 67 Italy Kyphoplasty Market, By End-Users, 2019-2027 (US$ Billion) 78
FIG. 68 Rest of Europe Kyphoplasty Market Size by Product Type, 2019-2027 (US$ Billion) 79
FIG. 69 Rest of Europe Kyphoplasty Market, By Application, 2019-2027 (US$ Billion) 79
FIG. 70 Rest of Europe Kyphoplasty Market, By End-Users, 2019-2027 (US$ Billion) 80
FIG. 71 Asia Pacific Kyphoplasty Market Size by Product Type, 2019-2027 (US$ Billion) 81
FIG. 72 Asia Pacific Kyphoplasty Market, By Application, 2019-2027 (US$ Billion) 82
FIG. 73 Asia Pacific Kyphoplasty Market, By End-User, 2019-2027 (US$ Billion) 82
FIG. 74 Asia Pacific Kyphoplasty Market Size by Country, 2019-2027 (US$ Billion) 83
FIG. 75 Japan Kyphoplasty Market Size by Product Type, 2019-2027 (US$ Billion) 84
FIG. 76 Japan Kyphoplasty Market, By Application, 2019-2027 (US$ Billion) 85
FIG. 77 Japan Kyphoplasty Market, By End-Users, 2019-2027 (US$ Billion) 85
FIG. 78 China Kyphoplasty Market Size by Product Type, 2019-2027 (US$ Billion) 87
FIG. 79 China Kyphoplasty Market, By Application, 2019-2027 (US$ Billion) 88
FIG. 80 China Kyphoplasty Market, By End-Users, 2019-2027 (US$ Billion) 88
FIG. 81 India Kyphoplasty Market Size by Product Type, 2019-2027 (US$ Billion) 90
FIG. 82 India Kyphoplasty Market, By Application, 2019-2027 (US$ Billion) 90
FIG. 83 India Kyphoplasty Market, By End-Users, 2019-2027 (US$ Billion) 91
FIG. 84 Australia Kyphoplasty Market Size by Product Type, 2019-2027 (US$ Billion) 92
FIG. 85 Australia Kyphoplasty Market, By Application, 2019-2027 (US$ Billion) 92
FIG. 86 Australia Kyphoplasty Market, By End-Users, 2019-2027 (US$ Billion) 93
FIG. 87 South Korea Kyphoplasty Market Size by Product Type, 2019-2027 (US$ Billion) 94
FIG. 88 South Korea Kyphoplasty Market, By Application, 2019-2027 (US$ Billion) 94
FIG. 89 South Korea Kyphoplasty Market, By End-Users, 2019-2027 (US$ Billion) 95
FIG. 90 Rest of Asia Pacific Kyphoplasty Market Size by Product Type, 2019-2027 (US$ Billion) 96
FIG. 91 Rest of Asia Pacific Kyphoplasty Market, By Application, 2019-2027 (US$ Billion) 96
FIG. 92 Rest of Asia Pacific Kyphoplasty Market, By End-Users, 2019-2027 (US$ Billion) 97
FIG. 93 Rest of the World Kyphoplasty Market Size by Product Type, 2019-2027 (US$ Billion) 98
FIG. 94 Rest of the World Kyphoplasty Market, By Application, 2019-2027 (US$ Billion) 98
FIG. 95 Rest of the World Kyphoplasty Market, By End-Users, 2019-2027 (US$ Billion) 99
FIG. 96 Porter's Five forces analysis of Kyphoplasty Market 101
FIG. 97 Market Share of Key Players in Kyphoplasty Market, 2019 (%) 104
FIG. 98 Merit Medical Systems, Timeline 106
FIG. 99 Merit Medical Systems, Global Facilities 108
FIG. 100 Merit Medical Systems, SWOT Analysis 109
FIG. 101 Key Financials of Merit Medical Systems 110
FIG. 102 Merit Medical Systems Revenue Split, 2019 111
FIG. 103 Stryker Corporation, SWOT Analysis 114
FIG. 104 Key Financials of Stryker Corporation 115
FIG. 105 Stryker Corporation, Revenue Split, 2019 116
FIG. 106 Medtronic, SWOT Analysis 120
FIG. 107 Key Financials of Medtronic 121
FIG. 108 Medtronic, Revenue Split, 2019 122
FIG. 109 CareFusion, SWOT Analysis 126
FIG. 110 Key Financials of CareFusion 127
FIG. 111 CareFusion, Revenue Split, 2019 128
FIG. 112 Alphatec Spine, SWOT Analysis 132
FIG. 113 Key Financials of Alphatec Spine 133
FIG. 114 Alphatec Spine, Revenue Split, 2019 134
FIG. 115 Osseon LLC, SWOT Analysis 138
FIG. 116 Key Financials of Osseon LLC 139
FIG. 117 Osseon LLC, Revenue Split, 2019 140
FIG. 118 DePuy Synthes, SWOT Analysis 144
FIG. 119 Key Financials of DePuy Synthes 145
FIG. 120 DePuy Synthes, Revenue Split, 2019 146
FIG. 121 Globus Medical, SWOT Analysis 150
FIG. 122 Key Financials of Globus Medical 151
FIG. 123 Globus Medical, Revenue Split, 2019 152
FIG. 124 Zimmer biomet, SWOT Analysis 156
FIG. 125 Key Financials of Zimmer biomet 157
FIG. 126 Zimmer biomet, Revenue Split, 2019 158
FIG. 127 Parallax Health Sciences, SWOT Analysis 162
FIG. 128 Key Financials of Parallax Health Sciences 163
FIG. 129 Parallax Health Sciences, Revenue Split, 2019 164
Merit Medical Systems
Stryker Corporation
Medtronic
CareFusion
Alphatec Spine
Osseon LLC
DePuy Synthes
Globus Medical
Zimmer Biomet
and Parallax Health Sciences